Terms: = Lymphoma AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
207 results:
1. Tiam1 regulates proliferation, invasion, and differentiation in neuroblastoma through the Tiam1/rac1 signaling pathway.
Li X; Liu B; Wang X; Zhuang Y; Gao T; Sun N
Neoplasma; 2024 Feb; 71(1):37-47. PubMed ID: 38506031
[TBL] [Abstract] [Full Text] [Related]
2. Tiam1 methylation by NSD2 promotes rac1 signaling activation and colon cancer metastasis.
Song D; Hu F; Huang C; Lan J; She X; Zhao C; Wu H; Liu A; Wu Q; Chen Y; Luo X; Feng Y; Yang X; Xu C; Hu J; Wang G
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2305684120. PubMed ID: 38113258
[TBL] [Abstract] [Full Text] [Related]
3. Regulatory roles of CARD9-BCL10-rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1?
Kowluru A
Biochem Pharmacol; 2023 Dec; 218():115889. PubMed ID: 37991197
[TBL] [Abstract] [Full Text] [Related]
4. The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
Liu Y; Li Y; Wu Y; Zhao Y; Hu X; Sun C
J Ovarian Res; 2023 Nov; 16(1):219. PubMed ID: 37986114
[TBL] [Abstract] [Full Text] [Related]
5. A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.
Ginn L; Maltas J; Baker MJ; Chaturvedi A; Wilson L; Guilbert R; Amaral FMR; Priest L; Mole H; Blackhall F; Diamantopoulou Z; Somervaille TCP; Hurlstone A; Malliri A
Proc Natl Acad Sci U S A; 2023 Oct; 120(40):e2300489120. PubMed ID: 37748077
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of miR-22 alleviates oxygen-glucose deprivation/reperfusion-induced injury by targeting Tiam1 in SH-SY5Y cells.
Yin J; Wan Y; Wang J; Xue M
Acta Biochim Pol; 2023 Sep; 70(3):495-501. PubMed ID: 37672720
[TBL] [Abstract] [Full Text] [Related]
7. TIAM1 acts as an actin organization regulator to control adipose tissue-derived pericyte cell fate.
Hsu GC; Wang Y; Lu AZ; Gomez-Salazar MA; Xu J; Li D; Meyers C; Negri S; Wangsiricharoen S; Broderick K; Peault B; Morris C; James AW
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37219951
[TBL] [Abstract] [Full Text] [Related]
8. Identification of
Permtermsin C; Lalchungnunga H; Nakjang S; Casement J; Ogle LF; Reeves HL; Strathdee G; Shukla R
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047360
[TBL] [Abstract] [Full Text] [Related]
9.
Wu X; Li Y; Zhang W; Zhang J; Chen B; Ge Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552804
[TBL] [Abstract] [Full Text] [Related]
10. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
Delage L; Lambert M; Bardel É; Kundlacz C; Chartoire D; Conchon A; Peugnet AL; Gorka L; Auberger P; Jacquel A; Soussain C; Destaing O; Delecluse HJ; Delecluse S; Merabet S; Traverse-Glehen A; Salles G; Bachy E; Billaud M; Ghesquières H; Genestier L; Rouault JP; Sujobert P
Blood; 2023 Mar; 141(10):1209-1220. PubMed ID: 36375119
[TBL] [Abstract] [Full Text] [Related]
11. YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer.
Shen J; Huang Q; Jia W; Feng S; Liu L; Li X; Tao D; Xie D
Oncogene; 2022 Jul; 41(31):3830-3845. PubMed ID: 35773411
[TBL] [Abstract] [Full Text] [Related]
12. Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/rac1 Axis.
Zhang H; Wang C; Zhang X
Neurotox Res; 2022 Aug; 40(4):1007-1019. PubMed ID: 35726081
[TBL] [Abstract] [Full Text] [Related]
13. RHOA takes the RHOad less traveled to cancer.
Schaefer A; Der CJ
Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648
[TBL] [Abstract] [Full Text] [Related]
14. miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
Li N; Wang X; Sun J; Liu Y; Han A; Lin Z; Yang Y
Carcinogenesis; 2022 Aug; 43(7):705-715. PubMed ID: 35511493
[TBL] [Abstract] [Full Text] [Related]
15. Vav1 Promotes B-Cell lymphoma Development.
Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
[TBL] [Abstract] [Full Text] [Related]
16. Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures.
Lu S; Hernan R; Marcogliese PC; Huang Y; Gertler TS; Akcaboy M; Liu S; Chung HL; Pan X; Sun X; Oguz MM; Oztoprak U; de Baaij JHF; Ivanisevic J; McGinnis E; Guillen Sacoto MJ; Chung WK; Bellen HJ
Am J Hum Genet; 2022 Apr; 109(4):571-586. PubMed ID: 35240055
[TBL] [Abstract] [Full Text] [Related]
17. Syndecan-4 affects myogenesis via rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors.
Szabo K; Varga D; Vegh AG; Liu N; Xiao X; Xu L; Dux L; Erdelyi M; Rovo L; Keller-Pinter A
Cell Mol Life Sci; 2022 Feb; 79(2):122. PubMed ID: 35128576
[TBL] [Abstract] [Full Text] [Related]
18. TIAM1-rac1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.
Payapilly A; Guilbert R; Descamps T; White G; Magee P; Zhou C; Kerr A; Simpson KL; Blackhall F; Dive C; Malliri A
Cell Rep; 2021 Nov; 37(6):109979. PubMed ID: 34758330
[TBL] [Abstract] [Full Text] [Related]
19. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
[TBL] [Abstract] [Full Text] [Related]
20. T-lymphoma invasion and metastasis 1 promotes invadopodia formation and is regulated by the PI3K/Akt signaling pathway in hepatocellular carcinoma.
Wang B; Zheng B; Cao L; Liao K; Huang D; Zhang Y; Jiang Y; Zheng S
Exp Cell Res; 2021 Oct; 407(2):112806. PubMed ID: 34487727
[TBL] [Abstract] [Full Text] [Related]
[Next]
